MC-Val-Cit-PAB-MMAF Catalog No.:M25519-C 3)22-13(20)15-7-9-21-8-6-12(19)23-16-10(17)4-5-11(16)18/h4-9H2

3)22-13(20)15-7-9-21-8-6-12(19)23-16-10(17)4-5-11(16)18/h4-9H2

And the HBeAg inhibition rate is higher than the HBsAg inhibition rate in HepG2

including those with the ubiquitous His274Tyr substitution

5-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-4

JYL 1421 dose-dependently inhibits the capsaicin-induced fall in blood pressure as shown by the need for higher capsaicin doses to elicit the reflex hypotension after JYL 1421 administration than before treatment

MC-Val-Cit-PAB-MMAF Catalog No.:M25519-C 3)22-13(20)15-7-9-21-8-6-12(19)23-16-10(17)4-5-11(16)18/h4-9H2MC Val Cit PAB MMAF is a drug linker conjugate for ADC with antitumor activity by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC Val Cit PAB. Product information CAS Number: 863971 17 9 Molecular Weight: 1330. 61 Formula: C68H103N11O16 Chemical Name: 2 {2 [(1 {4 [2 (2 {[({4 [5 (carbamoylamino) 2 {2 [6 (2,5 dioxo 2,5 dihydro 1H pyrrol 1 yl)hexanamido] 3 methylbutanamido}pentanamido]phenyl}methoxy)carbonyl](methyl)amino} 3